<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04882202</url>
  </required_header>
  <id_info>
    <org_study_id>3-2021-0087</org_study_id>
    <nct_id>NCT04882202</nct_id>
  </id_info>
  <brief_title>Acetaminophen and AKI After Aortic Surgery</brief_title>
  <official_title>Effect of Acetaminophen on the Incidence of Acute Kidney Injury in Patients Undergoing Aortic Surgery With Moderate Hypothermic Circulatory Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury is commonly accompanied major complication after aortic surgery.&#xD;
&#xD;
      Cardipulmonary bypass lyses erythrocyte and induces lipid peroxidation. This increases plasma&#xD;
      free hemoglobin, F2-isoprostane, and isofuran concentration. Cell free hemoglobin have been&#xD;
      reported to be associated with poor prognosis such as acute kidney injury, myocardial&#xD;
      infarction, and death.&#xD;
&#xD;
      Acetaminophen is reported to attenuate hemeprotein mediated lipid peroxidation. Thus,&#xD;
      investigators hypothesized that acetaminophen might have protective effect on the incidence&#xD;
      of acute kidney injury in patients undergoing aortic surgery with moderate hypothermic&#xD;
      circulatory arrest.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of acute kidney injury after aortic surgery with moderate hypothermic circulatory arrest</measure>
    <time_frame>Postoperative 7 days</time_frame>
    <description>Compare the incidence of acute kidney injury within 7 days after surgery. Acute kidney injury is defined using KDIGO criteria.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">136</enrollment>
  <condition>Aortic Surgery</condition>
  <arm_group>
    <arm_group_label>Acetaminophen group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients receiving acetaminophen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients receiving equal amount of normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Acetaminophen 1g IV every 6 hours for a weight &gt; 50kg (maximum of 4g per 24 hours) or 15mg/kg every 6 hours for a weight &lt; 50kg (maximum of 75mg/kg per 24 hours)</description>
    <arm_group_label>Acetaminophen group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline 100 ml (equal amount of acetaminophen) IV every 6 hours</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1) Patients undergoing aortic surgery with moderate hypothermic circulatory arrest.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. patients with chronic kidney disease or with dialysis, eGFR &lt; 15ml/min/1.73m2&#xD;
&#xD;
          2. allergy to acetaminophen or propacetamol HCl&#xD;
&#xD;
          3. history of liver cirrhosis or total bilirubin &gt; 2.0mg/dL&#xD;
&#xD;
        3) patients taking acetaminophen or diclofenac 4) patients who cannot understand informed&#xD;
        consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Simpson SA, Zaccagni H, Bichell DP, Christian KG, Mettler BA, Donahue BS, Roberts LJ 2nd, Pretorius M. Acetaminophen attenuates lipid peroxidation in children undergoing cardiopulmonary bypass. Pediatr Crit Care Med. 2014 Jul;15(6):503-10. doi: 10.1097/PCC.0000000000000149.</citation>
    <PMID>24732290</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 6, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2021</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gangnam Severance Hospital</investigator_affiliation>
    <investigator_full_name>Sung Yeon Ham</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

